Latest Articles

Publication Date
All News Scientific
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - BioSpace

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer BioSpace

Published: Feb. 4, 2026, 4:47 a.m.
Read Full Article
Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer - TradingView

Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer TradingView

Published: Feb. 3, 2026, 1:11 p.m.
Read Full Article
Why Endometrial Cancer Is Rising Among Younger Women And What Doctors Want You To Know - News18

Why Endometrial Cancer Is Rising Among Younger Women And What Doctors Want You To Know News18

Published: Feb. 3, 2026, 1:06 p.m.
Read Full Article
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Newswire Canada

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Newswire …

Published: Feb. 3, 2026, 1 p.m.
Read Full Article
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Yahoo Finance Singapore

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Yahoo …

Published: Feb. 3, 2026, 1 p.m.
Read Full Article
How Patients Define Treatment Options in Endometrial Cancer Trials - Medscape

How Patients Define Treatment Options in Endometrial Cancer Trials Medscape

Published: Feb. 2, 2026, 7:08 p.m.
Read Full Article
Thomas Hofmarcher: Endometrial Cancer Case Study in Taiwan - Oncodaily

Thomas Hofmarcher: Endometrial Cancer Case Study in Taiwan Oncodaily

Published: Feb. 1, 2026, 4:57 a.m.
Read Full Article
Complication Rates and Management in Sentinel Lymph Node Biopsy for Endometrial Cancer: A Retrospective Cohort Study - Frontiers

Complication Rates and Management in Sentinel Lymph Node Biopsy for Endometrial Cancer: A Retrospective Cohort Study Frontiers

Published: Jan. 30, 2026, 6:10 p.m.
Read Full Article
Myriam Saadi: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings - Oncodaily

Myriam Saadi: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings Oncodaily

Published: Jan. 30, 2026, 5:27 p.m.
Read Full Article
Aprea Therapeutics Reports Early Clinical Activity of APR-1051 in Advanced Endometrial Cancer with Significant Tumor Reduction - Quiver Quantitative

Aprea Therapeutics Reports Early Clinical Activity of APR-1051 in Advanced Endometrial Cancer with Significant Tumor Reduction Quiver Quantitative

Published: Jan. 29, 2026, 1:31 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!